학술논문

The effects of higher versus lower protein delivery in critically ill patients: an updated systematic review and meta-analysis of randomized controlled trials with trial sequential analysis
Document Type
Report
Source
Critical Care. January 6, 2024, Vol. 28 Issue 1
Subject
International economic relations
Comparative analysis
Health aspects
Mortality -- Comparative analysis
Urea -- Health aspects -- Comparative analysis
Online searching -- Comparative analysis -- Health aspects
Database searching -- Comparative analysis -- Health aspects
Internet/Web search services -- Comparative analysis -- Health aspects
Language
English
ISSN
1364-8535
Abstract
Author(s): Zheng-Yii Lee[sup.1,2], Ellen Dresen[sup.3], Charles Chin Han Lew[sup.4], Julia Bels[sup.5,6], Aileen Hill[sup.7], M. Shahnaz Hasan[sup.1], Lu Ke[sup.8], Arthur van Zanten[sup.9], Marcel C. G. van de Poll[sup.5,6], Daren K. Heyland[sup.10] [...]
Background A recent large multicentre trial found no difference in clinical outcomes but identified a possibility of increased mortality rates in patients with acute kidney injury (AKI) receiving higher protein. These alarming findings highlighted the urgent need to conduct an updated systematic review and meta-analysis to inform clinical practice. Methods From personal files, citation searching, and three databases searched up to 29-5-2023, we included randomized controlled trials (RCTs) of adult critically ill patients that compared higher vs lower protein delivery with similar energy delivery between groups and reported clinical and/or patient-centred outcomes. We conducted random-effect meta-analyses and subsequently trial sequential analyses (TSA) to control for type-1 and type-2 errors. The main subgroup analysis investigated studies with and without combined early physical rehabilitation intervention. A subgroup analysis of AKI vs no/not known AKI was also conducted. Results Twenty-three RCTs (n = 3303) with protein delivery of 1.49 [+ or -] 0.48 vs 0.92 [+ or -] 0.30 g/kg/d were included. Higher protein delivery was not associated with overall mortality (risk ratio [RR]: 0.99, 95% confidence interval [CI] 0.88-1.11; I.sup.2 = 0%; 21 studies; low certainty) and other clinical outcomes. In 2 small studies, higher protein combined with early physical rehabilitation showed a trend towards improved self-reported quality-of-life physical function measurements at day-90 (standardized mean difference 0.40, 95% CI - 0.04 to 0.84; I.sup.2 = 30%). In the AKI subgroup, higher protein delivery significantly increased mortality (RR 1.42, 95% CI 1.11-1.82; I.sup.2 = 0%; 3 studies; confirmed by TSA with high certainty, and the number needed to harm is 7). Higher protein delivery also significantly increased serum urea (mean difference 2.31 mmol/L, 95% CI 1.64-2.97; I.sup.2 = 0%; 7 studies). Conclusion Higher, compared with lower protein delivery, does not appear to affect clinical outcomes in general critically ill patients but may increase mortality rates in patients with AKI. Further investigation of the combined early physical rehabilitation intervention in non-AKI patients is warranted. Prospero ID CRD42023441059. Keywords: Critical illness, Protein, Physical rehabilitation, Systematic review